CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

First healthy volunteers dosed in Bionyra’s Phase I BYN-001 study

Phase 1BYN-001Neutral
AI Analysis

Summary

Bionyra Pharma has initiated dosing of the first healthy volunteers in a Phase 1 trial of BYN-001, a long-acting anti-IL-25 monoclonal antibody.

Clinical Trial Data

Phase

Phase 1

Outcome Details

First healthy volunteers dosed

Importance:3/10
Sentiment:
0.20
Phase 1monoclonal antibodyIL-25first-in-human
Related Companies

Read the original article

Published by Clinical Trials Arena on September 11, 2026 9:36 AM

Read Original